tradingkey.logo
tradingkey.logo
Search

Context Therapeutics Inc

CNTX
Add to Watchlist
0.181USD
-0.017-8.59%
Close 11-13 16:00(ET)
16.63MMarket Cap
LossP/E TTM
After-hours 18:22 (ET)0.184USD-0.003-1.60%

CNTX Financials

See Context Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
16.63M
Dividend TTM
0.00
P/E TTM
-0.44
EPS TTM
-0.42
Revenue
--
Net Profit
-26.73M
ROE
-56.19%
ROA
-52.99%
Context Therapeutics Inc Earnings Date
Latest Release
Aug 5, 2026
EPS / Forecast
-0.15/-0.09
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
21.36%-0.08
-64.92%-0.15
-89.64%-0.09
-235.42%-0.14
53.06%-0.10
-126.08%-0.09
79.07%-0.05
90.38%-0.04
41.04%-0.22
86.93%-0.04
41.86%-0.23
-90.34%-0.42
---0.37
---0.31
---0.40
---0.22
----
----
----
----
Net Profit
21.35%-7.62M
-64.92%-14.56M
-89.65%-8.68M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
-293.99%-3.09M
Operating profit
24.97%-7.96M
-53.38%-14.97M
-68.99%-9.34M
-220.26%-13.80M
43.26%-10.61M
-215.95%-9.76M
-44.61%-5.53M
37.83%-4.31M
-202.59%-18.70M
41.64%-3.09M
42.65%-3.82M
-78.58%-6.93M
-52.68%-6.18M
-50.87%-5.29M
-93.63%-6.67M
-25.56%-3.88M
-158.16%-4.05M
-81.03%-3.51M
-309.72%-3.44M
-301.78%-3.09M
Net Profit
21.35%-7.62M
-64.92%-14.56M
-89.65%-8.68M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-15.04%-3.56M
-167.14%-3.85M
20.75%-3.99M
-285.44%-3.44M
-293.99%-3.09M
Current assets
-54.12%36.27M
-47.30%45.82M
-36.90%58.52M
-30.18%68.35M
-8.15%79.06M
-15.34%86.95M
740.05%92.73M
510.05%97.90M
274.70%86.07M
270.63%102.70M
-65.38%11.04M
-57.61%16.05M
-45.23%22.97M
-37.73%27.71M
-31.95%31.89M
-26.15%37.85M
9485.42%41.94M
3320.20%44.50M
2704.60%46.86M
--51.26M
Total current liabilities
-8.86%5.50M
73.08%7.88M
243.88%6.53M
191.80%8.02M
158.82%6.04M
183.94%4.56M
-27.15%1.90M
-34.43%2.75M
-49.35%2.33M
-57.30%1.60M
-19.33%2.61M
30.68%4.19M
14.76%4.60M
23.62%3.76M
101.25%3.23M
5.74%3.21M
-9.01%4.01M
-23.23%3.04M
-51.89%1.61M
--3.03M
Total assets
-53.88%36.54M
-47.06%46.13M
-36.69%58.86M
-30.20%68.49M
-8.22%79.23M
-15.15%87.15M
741.19%92.97M
510.90%98.13M
275.53%86.33M
269.96%102.71M
-65.43%11.05M
-57.69%16.06M
-45.37%22.99M
-37.89%27.76M
-32.03%31.97M
-26.00%37.97M
1762.65%42.08M
1543.71%44.70M
1989.00%47.03M
--51.31M
Total liabilities
-8.66%5.53M
72.80%7.96M
235.73%6.66M
180.37%8.02M
145.00%6.06M
187.21%4.61M
-23.99%1.98M
-31.76%2.86M
-46.30%2.47M
-57.30%1.60M
-19.33%2.61M
30.68%4.19M
14.76%4.60M
23.30%3.76M
97.36%3.23M
5.74%3.21M
-9.01%4.01M
-23.03%3.05M
-51.34%1.64M
--3.03M
Total equity
-57.63%31.01M
-53.76%38.17M
-42.62%52.20M
-36.52%60.47M
-12.74%73.17M
-18.36%82.54M
977.58%90.98M
702.51%95.27M
356.12%83.86M
321.19%101.10M
-70.61%8.44M
-65.85%11.87M
-51.71%18.38M
-42.36%24.00M
-36.70%28.73M
-28.00%34.76M
1871.34%38.07M
3458.18%41.65M
4169.15%45.39M
--48.27M
Net operating income
-0.01%-6.58M
-20.30%-7.02M
-127.30%-11.43M
-82.26%-8.94M
-240.29%-6.58M
-73.89%-5.84M
-15.31%-5.03M
32.11%-4.91M
44.14%-1.93M
27.54%-3.36M
23.88%-4.36M
-83.91%-7.23M
-15.59%-3.46M
-65.09%-4.63M
-49.95%-5.73M
20.80%-3.93M
-6762.00%-2.99M
-34.93%-2.81M
-122.72%-3.82M
-2718.74%-4.96M
Net investment
---2.00M
---4.52M
-9.75%-37.26K
---2.00M
100.00%0.00
--0.00
---33.95K
--0.00
---14.76M
----
----
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---500.00K
99.27%-1.84K
---35.00K
--0.00
Net financing
--0.00
--0.00
100.00%0.00
-100.00%0.00
100.00%0.00
-100.00%0.00
---15.27K
--14.54M
---44.63K
--94.80M
----
--0.00
--0.00
--0.00
100.00%0.00
-100.00%0.00
100.00%0.00
-100.00%0.00
-103.36%-102.07K
15393.75%54.23M

FAQs

What are the current assets of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its current assets were 68.35M, with a year-on-year change of -30.18.

What are the total assets of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its total assets of Context Therapeutics Inc were 68.49M, with a year-on-year change of -30.20.

What are the total liabilities of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its total liabilities of Context Therapeutics Inc were 8.02M, with a year-on-year change of 180.37.

What is the total equity of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its total equity of Context Therapeutics Inc was 60.47M, with a year-on-year change of -36.52.

What is the net operating income of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its net operating income of Context Therapeutics Inc was -39.70M, with a year-on-year change of -32.68.

What is the net investment of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its net investment of Context Therapeutics Inc was -2.03M, with a year-on-year change of 86.22.

What is the net financing of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its net financing of Context Therapeutics Inc was -15.27K, with a year-on-year change of -100.01.

What is the Earnings Per Share (EPS) of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.38, with a year-on-year change of 17.05.

What is the net income of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its net income was -36.12M, with a year-on-year change of -35.17.

What is the Return on Equity (ROE) of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -46.39, with a year-on-year change of 7.02.

What is the Return on Assets (ROA) of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -43.36, with a year-on-year change of 7.37.

What is the operating profit of Context Therapeutics Inc?

According to Context Therapeutics Inc's FY2025 earnings report, its operating profit was -39.70M, with a year-on-year change of -32.68.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.